Per una migliore esperienza, mantieni il tuo browser aggiornato. Controlla qui le ultime versioni.
ACT

News

Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

Leggi

Zambon Completes Enrollment in Phase 3 Clinical Development Program Evaluating Liposomal Cyclosporine A for Inhalation (L-CsA-i) in Patients with Bronchiolitis Obliterans Syndrome (BOS)

Leggi

Enthera Pharmaceuticals Inizia lo studio Clinico di fase 1 con il nuovo candidato terapeutico Ent001

Leggi

VITA Accelerator: The 2023 Call For Applications Is Open!

Leggi